Susan E. Knight's most recent trade in Surmodics, Inc. was a trade of 37,240 Common Stock done . Disclosure was reported to the exchange on Nov. 19, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Surmodics Inc | Susan E. Knight | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 37,240 | 0 (0%) | 0% | - | Common Stock | |
| Surmodics Inc | Susan E. Knight | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 5,040 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | Susan E. Knight | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 4,548 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | Susan E. Knight | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 4,155 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | Susan E. Knight | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 3,634 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | Susan E. Knight | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 3,555 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | Susan E. Knight | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 3,196 | 0 | - | - | Employee Stock Options (right to buy) | |
| Surmodics Inc | Susan E. Knight | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.30 per share. | 24 Jan 2025 | 7,358 | 42,506 (0%) | 0% | 27.3 | 200,873 | Common Stock |
| Surmodics Inc | Susan E. Knight | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jan 2025 | 7,358 | 0 | - | - | Stock Option (right to buy) | |
| Surmodics Inc | Susan E. Knight | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.15 per share. | 24 Jan 2025 | 5,266 | 37,240 (0%) | 0% | 38.2 | 200,898 | Common Stock |
| Surmodics Inc | E. Knight Susan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 4,155 | 4,155 | - | - | Stock Option (right to buy) | |
| Surmodics Inc | Knight E. Susan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 1,944 | 35,148 (0%) | 0% | 0 | Common Stock | |
| Surmodics Inc | Susan E. Knight | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 5,040 | 5,040 | - | - | Stock Option (right to buy) | |
| Surmodics Inc | Susan E. Knight | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 2,139 | 32,335 (0%) | 0% | 0 | Common Stock | |
| Surmodics Inc | Susan E. Knight | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.18 per share. | 28 Feb 2022 | 4,366 | 34,562 (0%) | 0% | 20.2 | 88,106 | Common Stock |
| Surmodics Inc | Susan E. Knight | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2022 | 4,366 | 0 | - | - | Stock Option (right to buy) | |
| Surmodics Inc | Susan E. Knight | Director | Sale of securities on an exchange or to another person at price $ 44.97 per share. | 28 Feb 2022 | 4,366 | 30,196 (0%) | 0% | 45.0 | 196,332 | Common Stock |
| Surmodics Inc | Susan E. Knight | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 3,834 | 3,834 | - | - | Stock Option (right to buy) | |
| Surmodics Inc | Susan E. Knight | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 1,482 | 30,196 (0%) | 0% | 0 | Common Stock | |
| Surmodics Inc | Susan E. Knight | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2021 | 5,576 | 0 | - | - | Stock Option (right to buy) | |
| Surmodics Inc | Susan E. Knight | Director | Sale of securities on an exchange or to another person at price $ 52.36 per share. | 26 Feb 2021 | 5,576 | 28,714 (0%) | 0% | 52.4 | 291,955 | Common Stock |
| Surmodics Inc | Susan E. Knight | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.31 per share. | 26 Feb 2021 | 5,576 | 34,290 (0%) | 0% | 21.3 | 118,825 | Common Stock |
| Surmodics Inc | Susan E. Knight | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 3,196 | 3,196 | - | - | Stock Option (right to buy) | |
| Surmodics Inc | Susan E. Knight | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 1,151 | 28,714 (0%) | 0% | 0 | Common Stock |